Targeted therapy of BRAF V600E‐mutant histiocytic sarcoma: A case report and review of the literature

2019 ◽  
Vol 103 (4) ◽  
pp. 444-448 ◽  
Author(s):  
Benoît Branco ◽  
Thibault Comont ◽  
Loïc Ysebaert ◽  
Muriel Picard ◽  
Camille Laurent ◽  
...  
2013 ◽  
Vol 45 (4) ◽  
pp. 1017-1021 ◽  
Author(s):  
Rui-ning Zhao ◽  
Li-hong Nie ◽  
Rui Gong ◽  
Jian-zhong Wang ◽  
Romel Wazir ◽  
...  

2014 ◽  
Vol 48 (3) ◽  
pp. 258 ◽  
Author(s):  
Dakeun Lee ◽  
Young-Bae Kim ◽  
Sook Hee Chung ◽  
Sang-Ryung Lee ◽  
Cheul Su Byun ◽  
...  

2008 ◽  
Vol 204 (10) ◽  
pp. 763-770 ◽  
Author(s):  
Xiaohong Zhang ◽  
John J. Kryston ◽  
William A. Michalak ◽  
Kai Zhang ◽  
Fan Lin ◽  
...  

2019 ◽  
Vol 13 (2) ◽  
pp. 153-157
Author(s):  
Hiroko Hasegawa ◽  
Yoko Nagata ◽  
Yuko Sakakibara ◽  
Masakazu Miyake ◽  
Kiyoshi Mori ◽  
...  

2019 ◽  
Vol 9 ◽  
Author(s):  
Louis Garnier ◽  
François Ducray ◽  
Clotilde Verlut ◽  
Marcella-Ionela Mihai ◽  
Françoise Cattin ◽  
...  

2019 ◽  
pp. 1-2
Author(s):  
Keun Joo Ryu*

Histiocytic sarcoma is very rare malignant neoplasm showing morphological and immunophenotypic characteristics of histiocyte. Morphologic diagnosis is challenging due to overlapping histologic features with diverse mimics. Histologic diagnosis is confirmed by expression of one or more histiocytic markers, including CD163, CD68, and lysozyme. We present a bona fida case of extranodal histiocytic sarcoma involving the small intestine in a 67-year-old male. The diagnosis is confirmed by diffuse immunoreactivity of CD163, which is believed to be more specific histiocytic marker than CD68.


2015 ◽  
Vol 31 (12) ◽  
pp. 2363-2368 ◽  
Author(s):  
Mitchell Foster ◽  
Ian Kamaly-Asl ◽  
Stavros Stivaros ◽  
Anna Kelsey ◽  
Rao Gattamenini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document